63326-69-2

Basic information

• Product Name: 2-Propanol, 1-(octadecyloxy)-3-(triphenylmethoxy)-, 4-methylbenzenesulfonate
• CAS NO: 63326-69-2
• Molecular Formula: C47H64O5S
• Molecular Weight: 741.088
• Mol File: 63326-69-2.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 2-Propanol, 1-(octadecyloxy)-3-(triphenylmethoxy)-, 4-methylbenzenesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Propanol, 1-(octadecyloxy)-3-(triphenylmethoxy)-, 4-methylbenzenesulfonate(63326-69-2)
• EPA Substance Registry System: 2-Propanol, 1-(octadecyloxy)-3-(triphenylmethoxy)-, 4-methylbenzenesulfonate(63326-69-2)

Safety Data

• Hazardous Substances Data: 63326-69-2(Hazardous Substances Data)

Upstream product

• 86334-56-7 1-octadecyloxy-3-trityloxy-propan-2-ol 
• 98-59-9 p-toluenesulfonyl chloride 
• 16725-43-2 4-(n-octadecyloxymethyl)-2,2-dimethyl-1,3-dioxolane 
• 3386-32-1 n-octadecyl p-toluenesulfonate 
• 76-83-5 trityl chloride 
• 544-62-7 batyl alcohol 

Downstream Products

• 179458-12-9 1-(1-Octadecyloxymethyl-2-trityloxy-ethyl)-1H-imidazole 
• 179458-13-0 1-(1-Octadecyloxymethyl-2-trityloxy-ethyl)-1H-[1,2,4]triazole 
• 99790-92-8 3-octadecyloxy-2-aminopropane-1-ol 
• 99790-83-7 3-octadecyloxy-2-phthalimido-1-trityloxypropane 
• 108225-24-7 3-benzyloxy-2-hydroxypropyl octadecyl ether 
• 16245-97-9 octadecyl glycidyl ether 
• 124133-84-2 Toluene-4-sulfonic acid 1-hydroxymethyl-2-octadecyloxy-ethyl ester 
• 63326-70-5 2-fluoro-1-octadecyloxy-3-trityloxy-propane 

Relevant articles and documents

Aminoheterocycle-substituted glycerols

Aminoheterocycle-substituted glycerols of Formula I are disclosed: STR1 wherein one of A, B or C is --X--R, wherein X is --O-- or --S--, and R is a substituted or unsubstituted C12-24 alkyl or alkenyl, the substituent being one or more of halo,

Heteroaryl-Substituted Deoxy Glycero-Phosphoethanolamines

Therapeutically active, heteroaryl-substituted deoxy glycero-phosphoethanolamines are disclosed having the general Formula I: STR1 wherein one of X, Y or Z is a fatty ether substituent, one is a heteroaryl ring substituent with 1-4 nitrogens as the only heteroatoms, one of which is bonded to a carbon of the glyceryl backbone, and one is a phosphoethanolamine substituent substituted at the nitrogen, provided that each of X, Y and Z is a different substituent, and the pharmaceutical compositions comprising the therapeutically active compounds and methods of using the therapetically active compounds to treat cancerous tumors, psoriasis and inflammation are also disclosed.

Certain 3-alkoxy-2-cyclic-imido-propyl-phosphate-ethyl-cyclic ammonium hydroxide inner salts which inhibit activities of platelet activating factor

A novel phospholipid of the formula: STR1 wherein R1 is an alkyl group of 10 to 24 carbon atoms, R2 is a cyclic imide group and A+ is a cyclic ammonio group and a salt thereof have platelet activating factor inhibiting act